Posted on

Moderna’s Vaccine News Bolsters Markets: Live Business Updates

Share
Credit…Justin Lane/EPA, via Shutterstock

As the number of coronavirus cases continues to reach record highs in the United States, nervous businesses are reacting by cutting services and tightening rules on mask mandates and purchase limits.

In the past week, an astonishing one million cases were recorded in the country, and states have responded to the growing crisis by enforcing stringent measures to contain the spread of the coronavirus. News of Moderna’s encouraging results on a vaccine on Monday gave some relief to Wall Street investors, but business are bracing for what could be a long winter as strict lockdown orders are put into effect.

  • American Airlines slashed flights between the United States and London in December by about two-thirds as coronavirus cases surge on both sides of the Atlantic, threatening already anemic international travel. The schedule adjustment leaves just one daily American flight to London next month, out of Dallas, after the airline dropped limited service from New York, Chicago and Charlotte, N.C.

  • Kroger, the grocery chain, has started to limit items that were in high demand during earlier surges in the pandemic, including bath tissue, paper towels, disinfecting wipes and hand soap. Customers can purchase only two of each of those products. The policy, enacted earlier this month across all Kroger stores and its website, was put in place “to ensure all customers have access to what they need,’’ the company said in a statement.

  • Wegmans added new items to the list of products with purchase limits. As of this past weekend, customers at the regional grocery chain can buy only one package of facial tissues and two packages of napkins. Since the spring, the company has restricted other items that have been in short supply during the pandemic, including disinfecting wipes and toilet paper. There are also limits on antacids and Wegmans brand peanut butter. To prevent shortages, the company said, it had been working to “build up our own holiday and winter reserves, in our own warehouses as well as at our suppliers.”

  • On Monday, Costco began requiring all members, guests and employees at all locations to wear a face mask or face shield. Previously, members who could not wear a mask because a medical condition were exempt; now, they must wear a face shield if they cannot wear a mask. “This updated policy may seem inconvenient to some, however we believe the added safety is worth any inconvenience,” Craig Jelinek, the company’s chief executive, said in a statement.

Credit…-/Agence France-Presse — Getty Images

On Monday, it was Moderna’s turn. The drugmaker, based in Cambridge, Mass., said it too had a vaccine candidate that had been surprisingly effective in early-stage clinical trials.

Moderna’s drug appears to 94.5 percent effective, the company said. Its announcement came a week after rival vaccine developers Pfizer and BioNTech said their candidate had efficacy rates of about 90 percent — itself an astonishing result.

The prospect of a vaccine has investors betting on life returning what it looked like before the pandemic. The S&P 500, which climbed to record territory on Friday, rose further on Monday, and companies that have been heavily battered by the pandemic, such as airlines and cruise companies, led the gains.

Moderna’s shares, of course, rose on the news — jumping about 8 percent in early trading. But Pfizer’s shares tumbled more than 4 percent, and BioNTech’s U.S.-listed shares dropped more than 13 percent. Also lower, though not nearly as sharply, were shares of AstraZeneca, which is developing a vaccine of its own.

Johnson & Johnson, which on Monday said it had started a late-stage trial for its vaccine to test the impact of a two-dose version, was slightly higher.

But the decline in shares of other companies is chalked up to the simple fact that as more vaccines prove effective, the potential rise in profits — and share prices — for the companies developing them could be limited.

That has analysts at J.P.Morgan advising against betting on any one winner, in particular because investors are already pricing in high probability of success for companies developing such drugs.

They remained “cautious on the ultimate opportunity on a company-specific level given the potential for many future vaccines and uncertainties around the duration of the pandemic,” the analysts wrote in a note to clients Monday.

In Pfizer and BioNTech’s case in particular, Moderna’s vaccine candidate has a potentially big competitive advantage because it doesn’t have to be stored at the extremely cold temperature.

  • Global markets started the week with a gain on Monday as investors saw positive signs in a new Asian free-trade deal and a report that a second coronavirus vaccine in development was highly effective in preliminary tests.

  • The S&P 500 rose more than 1 percent, after having ended trading on Friday at a record high. The Dow Jones industrial average rose about 1.5 percent, and was on track for its own record.

  • The gains came after Moderna, a drugmaker based in Cambridge, Mass., said its vaccine was 94.5 percent effective, based on an early look at the results from its large, continuing study. Moderna’s shares jumped more than 8 percent in early trading.

  • European markets jumped after Moderna’s news. The benchmark Stoxx Europe 600 doubled its gain for the day, up to 1.6 percent higher. Other European indexes rose by a similar amount. Earlier in the day, Asian shares closed higher, with the Shanghai Composite in China gaining 1.1 percent, while the Kospi index in South Korea ended 2 percent higher.

  • Oil futures also climbed. West Texas Intermediate, the U.S. benchmark, gained more than 4 percent. The yield on 10-year U.S. Treasury notes soared, as traders decided to take on riskier investments.

  • One of the world largest regional free-trade agreements — covering 15 Asian-Pacific nations, led by China — was formally approved on Sunday, signaling an effort by Beijing to curb American influence in the region. It follows a retreat by the United States from sweeping trade deals that reshape global relationships.

Credit…Joe Raedle/Getty Images

President-elect Joseph R. Biden Jr. and Vice President-elect Kamala Harris are set to deliver speeches on Monday on the slowing American economic recovery, amid the crosswinds of rising coronavirus deaths and soaring optimism over a vaccine.

Ahead of the remarks, Mr. Biden and Ms. Harris were scheduled to talk with business and union leaders to discuss the recovery, including Mary T. Barra, the chief executive of General Motors; Sonia Syngal, the chief executive of Gap; and Satya Nadella, the head of Microsoft. The union leaders will include Richard L. Trumka of the AFL-CIO and Rory Gamble, president of the United Automobile Workers.

Mr. Biden’s speech is expected to focus on the need to contain the virus to get the economy back on track, as well as ensuring that workers and businesses can operate safely. His remarks will touch on broad themes about the nation’s economic health and his plans for improving growth and equality in the short and long term.

His speech comes at a perilous moment for the recovery from the pandemic recession.

Credit card data and other indicators suggest consumers began to pull back spending this month as infection, hospitalization and death rates from the virus surge nationwide. States have begun to impose new restrictions on economic activity in an effort to tamp down the spread.

But stock markets were soaring again on Monday, encouraged by news that Moderna’s vaccine for the virus appears to be highly effective. Still, widespread distribution of a vaccine that would allow Americans to resume anything close to normal levels of travel, dining out and other services that have been crushed by the pandemic is likely months away. Economists continue to call for a new and immediate round of aid from Congress to help people and businesses weather the difficult time before the rebound is complete.

Mr. Biden’s first economic test will be navigating the politics of that aid package: whether to push his party to cut a deal with Republicans for a limited rescue bill this fall, before he takes office, or to hold out for a larger package after he is president.

Credit…Andrew Testa for The New York Times

As if a pandemic accompanied by a global economic downturn were not trouble enough, manufacturers in Britain are now confronting the intensifying possibility that their country may soon crash out of the European Union without a deal governing future commercial relations across the English Channel.

The prospect of a no-deal Brexit has long threatened to trigger job-killing, investment-discouraging mayhem in Britain and in major European economies, impeding the flow of goods through ports and rendering uncertain the rules applying to major industries — from finance to agriculture to manufacturing.

Now, that prospect is growing increasingly real. A transition period during which nothing has changed is set to expire at the end of the year. Barring a trade deal between Britain and the European Union, the transition will end abruptly, with the terms of trade unclear. Given that Britain sends nearly half its exports to the European bloc, a rupture in dealings could bring profound economic damage.

Prime Minister Boris Johnson of Britain has long sold Brexit as the beginning of a glorious new era that will bolster his country’s fortunes through expanded trade with the world. But his primary aspiration — a trade deal with the United States — was always more about political optics than economic gains. An agreement looks less likely with the electoral defeat of President Trump, a Johnson ally and Brexit champion. The incoming American president, Joseph R. Biden Jr., has favored multilateral trade blocs, like the one that Britain is abandoning.

British factories are bracing for fresh pain. Already battered by the pandemic, which has played out with especially lethal force in the Britain, and suffering lost sales in the face of the global recession, manufacturers in England are strongly inclined to view Brexit as another wound to manage, and not the spur to commerce portrayed by the government.

Only 3 percent of small and medium-size factories express confidence that Brexit will have a positive impact on their efforts to recover from the pandemic, according to a survey released Monday morning by a pair of trade associations, the South West Manufacturing Advisory Service and the Manufacturing Growth Program.

Small and medium-size manufacturers “have been battered by Covid-19, and now they have the additional challenge of recovering with Brexit looming large on the horizon,” Nick Golding, managing director of the manufacturing advisory service, said in a statement accompanying the release of the Manufacturing Barometer. “It’s like a perfect storm for management teams trying to plan.”

The report draws on surveys with more than 400 companies in England, polling them on their experiences between July and September. It found that 47 percent were confused about how the departure from the European Union would affect their businesses — a worrying finding given that 62 percent overall said their businesses remained below volumes before the pandemic.

One-fourth of respondents anticipated that recovery would take between one and five years, a process not helped by a breach with the nation’s largest trading partner.

President-elect Joseph R. Biden Jr. last week placed proponents of stronger regulation on financial regulatory teams, stoking fears by industry groups that he is preparing for an unexpected wave of corporate oversight.

It would be a sharp reversal from the Trump administration, which for four years benefited Wall Street with its push to loosen bank rules and weaken post-crisis financial regulations, Alan Rappeport and Jeanna Smialek reported.

Among those selected for the financial regulatory transition teams are Gary Gensler, who led the Commodity Futures Trading Commission during the Obama administration. He pushed through dozens of tough rules after the 2010 Dodd-Frank law, including some that the Trump administration has watered down.

Also on the teams are Leandra English, a former deputy director of the Consumer Financial Protection Bureau, and Dennis Kelleher, a co-founder of Better Markets, a prominent financial reform advocacy group. Ms. English tried, unsuccessfully, to prevent Mr. Trump from installing a critic of her bureau, Mick Mulvaney, as its acting director three years ago.

While a Biden presidency may be constrained by a divided Congress, regulatory agencies wield enormous power given their ability to write and interpret rules and decide how strictly to enforce them.

For example, a Biden administration could reinstate the consumer bureau’s efforts to limit payday lending and install leaders at the Securities and Exchange Commission and Labor Department who support “sustainable investing.”

Some view the “landing teams” as a sign that Mr. Biden is heeding the concerns of the progressive wing of his party and planning to put consumers ahead of corporations.

Banks, though wary, are not without a say in Washington.

“They get their voices heard enough — we know what they think,” Anat R. Admati, a professor of finance and economics at Stanford University’s Graduate School of Business and an expert in regulation, said of the banks. “There are a lot of people hurting in this economy. The financial sector is not among them.”

Credit…Ryan Pierse/Getty Images

The Australian Stock Exchange closed early on Monday following a glitch after upgrades went live, in the bourse’s worst outage since 2016.

Shortly after trading commenced at 10 a.m. local time, the exchange said it became aware of a market data issue. At 10:24 a.m., trading was paused. Before the stoppage, the S&P/ASX 200 index had been up 1.2 percent, its highest level since Feb. 27.

In the afternoon, the market said it would close for the rest of the day. In a statement, it said the issue had been identified and would be resolved overnight in time for normal trading on Tuesday.

“ASX is very disappointed with today’s outage and sorry for the disruption caused to investors, customers and other market users,” Dominic Stevens, the exchange’s managing director and chief executive, said in the statement.

ASX said a software issue related to the trading of multiple securities in a single order created inaccurate market data. Monday was the first day its Trade Refresh project, an update to its equity market trading platform, went live.

“Notwithstanding the extensive testing and rehearsals, and the involvement of our technology provider, ASX accepts responsibility. The obligation to get this right and provide a reliable and resilient trading system for the market rests with us,” Mr. Stevens said of the upgrade.

The outage is the longest since September 2016, when the exchange was shut for several hours at the open and close of trading because of a hardware failure.

Credit…T.J. Kirkpatrick for The New York Times

Jay Clayton, the former corporate lawyer who led the Securities and Exchange Commission during the Trump administration, will step down by the end of the year, he announced on Monday. The move was first reported in the DealBook newsletter.

In nearly four years as chairman, Mr. Clayton largely lived up to the pledge he delivered in his first speech on the job, forgoing “wholesale changes to the commission’s fundamental regulatory approach.” He presided over a regime largely free of drama or major changes at the agency — aside from a prominent battle with Tesla’s chief executive, Elon Musk.

When he was chosen to head the S.E.C. in 2017, few expected Mr. Clayton to make waves. He had spent decades as a lawyer at the white-shoe law firm Sullivan & Cromwell, working with clients like Alibaba, Barclays and Goldman Sachs. His nomination by President Trump to fill a term that expires in June 2021 was somewhat of a surprise, given that Mr. Clayton had been known for being largely apolitical.

His focus at the agency was protecting “the long-term interests of the Main Street investor,” he said. That approach surfaced in moves like stopping the car-rental company Hertz from selling stock while in bankruptcy protection and cracking down on cryptocurrency frauds.

He also expressed skepticism about the transparency of disclosures for special purpose acquisition companies, the blank-check investment funds known as SPACs that have become hot on Wall Street, echoing concerns that they may hurt ordinary investors at the expense of the savvy deal makers running them.

Critics contended that Mr. Clayton was too soft on business. But during his tenure, the commission pursued 3,152 enforcement cases, slightly more than the number brought by his predecessor, Mary Jo White, from 2013 to 2017, and also obtained orders for larger financial remedies than under the previous chief. That said, NPR reported that the S.E.C. brought just 32 insider-trading enforcement actions last year, the fewest since 1996.

The S.E.C.’s most prominent battle came when it sued Tesla in 2018 over Mr. Musk’s tweets about taking the carmaker private. It resulted in Mr. Musk stepping down as chairman and paying a $20 million fine. That same year, the commission accused Elizabeth Holmes, the founder of Theranos, of lying about her company’s blood-testing capabilities. It extracted a $500,000 settlement and barred her from serving as an executive or director of a public company for a decade, though the agency did not require her to admit guilt.

Mr. Clayton followed in the steps of many Republican leaders of the S.E.C. in pursuing deregulation. Under his watch, the commission loosened rules governing the independence of corporate auditors, adopted a conduct standard for brokers that consumer advocates argue weakened protections and proposed making most hedge funds exempt from publicly disclosing their stock holdings, generating widespread opposition.

One of the most memorable moments of Mr. Clayton’s tenure had to do with a different government post. Earlier this year, he told Attorney General Bill Barr that he was interested in becoming the U.S. attorney for the Southern District of New York, despite having never been a litigator. After Geoffrey Berman was fired from the post, a political firestorm effectively forced Mr. Clayton to back off.

It is unclear what Mr. Clayton plans to do next, though he is unlikely to take up another corporate role in the near term. Like other financial agencies, the commission is expected to get tougher on big business under President-elect Joseph R. Biden Jr.

Airbnb is expected to file its I.P.O. prospectus on Monday, joining a wave of tech businesses looking to go public this year. It is expected to seek to raise about $3 billion, and will list its shares on the Nasdaq.

Facebook’s Mark Zuckerberg and Twitter’s Jack Dorsey are back (virtually) at a Senate hearing on Tuesday, answering questions from the Judiciary Committee about how their platforms slowed the spread of a New York Post story about Hunter Biden. They last testified three weeks ago, and since then a member of the committee, Kamala Harris, has become the vice president-elect.

Pandemic shopping habits will be a theme of company earnings this week. Home Depot and Walmart on Tuesday, and Lowe’s and Target on Wednesday, are expected to report rising sales as consumers stock up on essentials and embark on lockdown home improvements. Hopes are dimmer for Macy’s on Thursday, as shoppers shy away from malls.

Credit…Yarek Waszul

The incoming administration’s first economic test is coming months before Inauguration Day. President-elect Joseph R. Biden Jr. must decide whether to push Democratic leaders to cut a quick deal on a package much smaller than they say is needed or to hold out hope for a larger one after he takes office, Ben Casselman and Jim Tankersley reported in The New York Times.

A slowing recovery and accelerating coronavirus infections give new urgency to talks on government aid to struggling households and businesses. Mr. Biden faces a short window for action in the lame-duck congressional session.

A standoff over aid could set the stage for sluggish growth that persists long into his presidency. Republican and Democratic leaders remain far apart on the size and contents of a rescue package, though both sides say lawmakers should act quickly.

Mr. Biden has until now sided with top Democrats in Congress. A Biden transition adviser said Friday that he had begun to have conversations with lawmakers about what a lame-duck package should look like.

The shifting dynamics of both the pandemic and the recovery are complicating the debate. Even as it has slowed, the economy has proved more resilient than many experts expected early in the coronavirus outbreak, leading Republicans, in particular, to resist a big new dose of federal aid. But the recent surge in hospitalizations and deaths from the virus has increased the risk that the economy could slow further.

Last spring, economists were nearly unanimous in urging Congress to provide as much money as possible, as quickly as it could. Now, many conservative economists say a much smaller follow-up package would suffice. Even as progressives point to slowing job creation and soaring long-term unemployment rates to argue for trillions of dollars in aid, a growing number of liberal economists are urging Democrats to compromise and accept a smaller package to get money flowing quickly.

“A meaningful something is a lot better than nothing,” said Jason Furman, who was a top economic adviser to former President Barack Obama. “Preventing damage to the economy today puts it in a better position a year from now.”

Credit…Brendan Mcdermid/Reuters

One of Goldman Sachs’s top deal makers and a co-head of its investment bank, Gregg R. Lemkau, is leaving the firm at year end, the Wall Street bank said on Monday.

He is joining the investment firm MSD Partners, which is affiliated with the family office of the billionaire technology executive Michael S. Dell.

Mr. Lemkau started his career at Goldman Sachs as an analyst in 1992, rising to become one of the bank’s most seasoned mergers advisers, particularly for technology, media and telecommunications companies. Before becoming co-head of the investment bank, he was a co-head of the firm’s global mergers group and a co-head of its tech, media and telecom team.

“Gregg has helped lead our efforts to continue to solidify and grow our pre-eminent investment banking franchise around the world,” David M. Solomon, Goldman’s chief executive, wrote in an internal memorandum, which was reviewed by The New York Times.

Investment banking has been a mainstay of Goldman’s business over the years, even as the firm has sought to diversify its sources of revenue into areas like consumer lending.

Jim Esposito, one of three leaders of the firm’s markets division, will replace Mr. Lemkau at the investment bank and will work alongside the other co-head, Dan Dees, Mr. Solomon said in a separate memo.

Credit…Amr Alfiky/The New York Times

President-elect Joseph R. Biden Jr. and Vice President-elect Kamala Harris are set to deliver speeches on Monday on the slowing American economic recovery, amid the crosswinds of rising coronavirus deaths and soaring optimism over a vaccine.

Ahead of the remarks, Mr. Biden and Ms. Harris were scheduled to talk with business and union leaders to discuss the recovery, including Mary Barra, the chief executive of General Motors, Sonia Syngal, the chief executive of Gap and Satya Nadella, the head of Microsoft. The union leaders will include Richard Trumka of the AFL-CIO and Rory Gamble, president of the United Auto Workers.

Mr. Biden’s speech is expected to focus on the need to contain the virus in order to get the economy back on track, as well as ensuring that workers and businesses can operate safely. His remarks will touch on broad themes about the nation’s economic health and his plans for improving growth and equality in the short and long term.

His speech comes at a perilous moment for the recovery from the pandemic recession.

Credit card data and other indicators suggest consumers began to pull back spending this month as infection, hospitalization and death rates from the virus surge nationwide. States have begun to impose new restrictions on economic activity in an effort to tamp down the spread.

But stock markets were soaring again on Monday, encouraged by news that Moderna’s vaccine for the virus appears to be highly effective. Still, widespread distribution of a vaccine that would allow Americans to resume anything close to normal levels of travel, dining out and other types of spending on services that have been crushed by the pandemic is likely months away. Economists continue to call for a new and immediate round of aid from Congress to help people and businesses weather the difficult time before the rebound is complete.

Mr. Biden’s first economic test will be navigating the politics of that aid package: whether to push his party to cut a deal with Republicans for a limited rescue bill this fall, before he takes office, or to hold out for a larger package after he is president.

Read More